Hypoglycemia denials in California external review

In the California DMHC record, independent physician reviewers decided 16 published external-review cases involving hypoglycemiaand overturned the plan’s denial in 93.8%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
16
2012–2025
Overturned
93.8%
15 denials reversed

Most-fought treatments for hypoglycemia

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Continuous Glucose Monitor3
100%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
12
91.7%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
4
100%
Typical time to a decision
9 days
Most land between 7 and 16 days
Handled as urgent
43.8%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Findings: The physician reviewer found that An enrollee has requested authorization and coverage for Dexcom G6 continuous glucose monitor system (including sensors, transmitters, and receiver). In this case, notes report diagnoses of hypoglycemia and Raynaud’s disease. The patient does not have diabetes. In an application for independent medical review, the patient reports having to test glucose levels using finger sticks several times daily. The patient reports that the use of finger sticks is challenging as Raynaud’s disease causes the patient's fingers to lack daily blood flow. The patient reports a history of dangerous hypoglycemia levels leading to a loss of consciousness. Hypoglycemia may occur in patients without diabetes due to multiple causes and is dangerous condition.
Experimental/Investigational · 2022 · IMR EI22-38120
Nature of Statutory Criteria/Case Summary: The patient is diagnosed with type 1 diabetes, hyperlipidemia, hypoglycemia, and left non-proliferative retinopathy. On 8/23/18, the patient’s hemoglobin A1c level was 7.4. In a report dated 1/24/19, the patient reported hypoglycemic episodes. His home blood glucose logs show frequent hypoglycemic events. The patient had been treated with Lantus and Humalog. On 2/5/19, the patient’s hemoglobin A1c level was 7.1. The patient’s provider adjusted his insulin doses to avoid hypoglycemia. The patient requested coverage for an insulin pump and continuous glucose monitor. The Health Plan denied the request and reported the requested equipment was not medically necessary for the evaluation and treatment of this patient.
Medical Necessity · 2019 · IMR MN19-30683

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for a medical alert bracelet. This patient presents with a history of diabetes and hypoglycemia. There is a lack of medical literature supporting the use of medical jewelry for diabetes or hypoglycemia. The Health Plan correctly stated that the medical bracelet is indicated for patients with anaphylaxis or with dementia. This patient does not report a history of anaphylaxis or dementia. Furthermore, the patient’s risk of hypoglycemia is markedly reduced with his continuous glucose monitor. All told, the requested medical alert bracelet is not medically necessary for the evaluation of the patient. Final Result: The reviewer determined that the requested device is not medically necessary for the evaluation of the patient’s medical condition. Therefore, the Health Plan’s denial should be upheld.
Medical Necessity · 2024 · IMR MN24-41309

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving hypoglycemia, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for hypoglycemia? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39